Newspaper article St Louis Post-Dispatch (MO)

Investors: 'Pharma Bro' Shkreli Was Shady - and Profitable

Newspaper article St Louis Post-Dispatch (MO)

Investors: 'Pharma Bro' Shkreli Was Shady - and Profitable

Article excerpt

NEW YORK * The jury at the securities fraud trial of Martin "Pharma Bro" Shkreli has heard investors accuse the quirky former biotech CEO of repeatedly giving them the runaround when they tried to pull their money out of his failing health care hedge fund.

But the government witnesses have made a concession that the defense hopes plays in its favor: In the end, they made a killing.

Whether jurors at the trial that began June 26 in federal court in Brooklyn will see Shkreli's clients as victims of a crime is central to a case that has featured odd subplots, including a self-serving rant by the defendant to reporters and email evidence by a mentor about wanting to touch his "soft skin."

Testimony resumed Thursday with the government still in the middle of its case. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.